Nissinen E - Search Results

1

Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.

Kaheinen P, Pollesello P, Hertelendi Z, Borbély A, Szilágyi S, Nissinen E, Haikala H, Papp Z. Kaheinen P, et al. Among authors: nissinen e. Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):74-8. doi: 10.1111/j.1742-7843.2006.pto_231.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16433895 Free article.

2

Biochemical properties of OR-1259--a positive inotropic and vasodilatory compound with an antiarrhythmic effect.

Raasmaja A, Talo A, Haikala H, Nissinen E, Lindén IB, Pohto P. Raasmaja A, et al. Among authors: nissinen e. Adv Exp Med Biol. 1992;311:423. doi: 10.1007/978-1-4615-3362-7_63. Adv Exp Med Biol. 1992. PMID: 1529781 No abstract available.

3

Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.

Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Lindén IB. Haikala H, et al. Among authors: nissinen e. J Cardiovasc Pharmacol. 1995 May;25(5):794-801. doi: 10.1097/00005344-199505000-00016. J Cardiovasc Pharmacol. 1995. PMID: 7630157

4

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan.

Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Lindén IB. Haikala H, et al. Among authors: nissinen e. J Mol Cell Cardiol. 1995 Sep;27(9):1859-66. doi: 10.1016/0022-2828(95)90009-8. J Mol Cell Cardiol. 1995. PMID: 8523447

5

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production.

Nissinen E, Kaheinen P, Penttilä KE, Kaivola J, Lindén IB. Nissinen E, et al. Eur J Pharmacol. 1997 Dec 11;340(2-3):287-94. doi: 10.1016/s0014-2999(97)01431-3. Eur J Pharmacol. 1997. PMID: 9537825

6

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

Pollesello P, Ovaska M, Kaivola J, Tilgmann C, Lundström K, Kalkkinen N, Ulmanen I, Nissinen E, Taskinen J. Pollesello P, et al. Among authors: nissinen e. J Biol Chem. 1994 Nov 18;269(46):28584-90. J Biol Chem. 1994. PMID: 7961805 Free article.

7

Antieosinophilic activity of simendans.

Kankaanranta H, Zhang X, Tumelius R, Ruotsalainen M, Haikala H, Nissinen E, Moilanen E. Kankaanranta H, et al. Among authors: nissinen e. J Pharmacol Exp Ther. 2007 Oct;323(1):31-8. doi: 10.1124/jpet.107.124057. Epub 2007 Jul 9. J Pharmacol Exp Ther. 2007. PMID: 17620456

8

Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462.

Schultz E, Nissinen E. Schultz E, et al. Among authors: nissinen e. Biochem Pharmacol. 1989 Nov 15;38(22):3953-6. doi: 10.1016/0006-2952(89)90673-4. Biochem Pharmacol. 1989. PMID: 2597177

9

Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli.

Sareila O, Korhonen R, Auvinen H, Hämäläinen M, Kankaanranta H, Nissinen E, Moilanen E. Sareila O, et al. Among authors: nissinen e. Br J Pharmacol. 2008 Nov;155(6):884-95. doi: 10.1038/bjp.2008.328. Epub 2008 Aug 18. Br J Pharmacol. 2008. PMID: 19002103 Free PMC article.

10

Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.

Schultz E, Tarpila S, Bäckström AC, Gordin A, Nissinen E, Pohto P. Schultz E, et al. Among authors: nissinen e. Eur J Clin Pharmacol. 1991;40(6):577-80. doi: 10.1007/BF00279973. Eur J Clin Pharmacol. 1991. PMID: 1884738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters